Article info
Clinical and epidemiological research
Concise report
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
- Correspondence to Shunsuke Mori, Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861-1196, Japan; moris{at}saisyunsou1.hosp.go.jp
Citation
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
Publication history
- Received September 12, 2012
- Revised November 21, 2012
- Accepted December 28, 2012
- First published January 23, 2013.
Online issue publication
April 12, 2023
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/